MetLife Investment Management’s ArriVent BioPharma AVBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $372K | Hold |
17,110
| – | – | ﹤0.01% | 1817 |
|
|
2025
Q1 | $316K | Sell |
17,110
-350
| -2% | -$6.47K | ﹤0.01% | 1941 |
|
|
2024
Q4 | $465K | Buy |
17,460
+1,110
| +7% | +$29.6K | ﹤0.01% | 1843 |
|
|
2024
Q3 | $384K | Buy |
16,350
+10,269
| +169% | +$241K | ﹤0.01% | 1924 |
|
|
2024
Q2 | $113K | Buy |
6,081
+567
| +10% | +$10.5K | ﹤0.01% | 2550 |
|
|
2024
Q1 | $98.5K | Buy |
+5,514
| New | +$98.5K | ﹤0.01% | 2547 |
|